Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04731675
What this trial is testing

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular Synovitis (PVNS)
AmMax Bio, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT06472531
What this trial is testing

PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer

Who this might be right for
Healthy Male SubjectsSuspected Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 32
Early research (Phase 1)Looking for participantsNCT06541639
What this trial is testing

EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors

Who this might be right for
Advanced or Recurrent Solid Tumors
Peking University 78
Early research (Phase 1)Study completedNCT01949545
What this trial is testing

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Solid TumorsHematologic MalignanciesHepatic Impairment
Amgen 46
Testing effectiveness (Phase 2)Study completedNCT00309166
What this trial is testing

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 270
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Early research (Phase 1)Study completedNCT00849550
What this trial is testing

Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificCancer
Herbert Hurwitz 32
Early research (Phase 1)Study completedNCT06949124
What this trial is testing

Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

Who this might be right for
EndometriosisUterine FibroidsAssisted Reproduction
Jiangsu HengRui Medicine Co., Ltd. 20
Early research (Phase 1)Study completedNCT00888108
What this trial is testing

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

Who this might be right for
Solid Tumor
Abbott 41
Testing effectiveness (Phase 2)Looking for participantsNCT06542250
What this trial is testing

Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Who this might be right for
B-cell Malignancies
AstraZeneca 174
Testing effectiveness (Phase 2)Study completedNCT00687323
What this trial is testing

Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic Syndrome
Merck Sharp & Dohme LLC 47
Not applicableUnknownNCT03454685
What this trial is testing

The Role of Microbiota on the Development of Lung Cancer

Who this might be right for
NSCLC, Stage INSCLC, Stage IINSCLC, Stage III+2 more
Xiaorong Dong 100
Testing effectiveness (Phase 2)Looking for participantsNCT06682780
What this trial is testing

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
LaNova Medicines Limited 320
Early research (Phase 1)Study completedNCT05347979
What this trial is testing

Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants

Who this might be right for
Cushing SyndromeNeoplasms
Corcept Therapeutics 30
Testing effectiveness (Phase 2)Ended earlyNCT02542215
What this trial is testing

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Who this might be right for
Oral Mucositis
Sucampo Pharma Americas, LLC 47
Early research (Phase 1)Study completedNCT01697020
What this trial is testing

Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

Who this might be right for
Acute Lymphoblastic Leukemia
Nova Laboratories Limited 70
Large-scale testing (Phase 3)Study completedNCT03952091
What this trial is testing

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseRefractory Multiple Myeloma
TJ Biopharma Co., Ltd. 289
Early research (Phase 1)Looking for participantsNCT05687682
What this trial is testing

Safety of AM-928 Infusion in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
AcadeMab Biomedical Inc. 38
Testing effectiveness (Phase 2)Ended earlyNCT03318562
What this trial is testing

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

Who this might be right for
Triple Negative Breast CancerHepatocellular Carcinoma
Effector Therapeutics 3
Testing effectiveness (Phase 2)UnknownNCT04640246
What this trial is testing

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

Who this might be right for
CancerTumor, SolidRefractory Cancer
Taiga Biotechnologies, Inc. 60
Next Page